Home > Insider Trading > Filing (0000899243-23-003085)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1707502	Solid Biosciences Inc.	SLDB	Biological Products, (No Disgnostic Substances) (2836)	900943402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727571	Ashley Carl Morris	C/O Solid Biosciences Inc. 500 Rutherford Avenue, Third Floor Charlestown MA 02129	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-27	1,233	$0.00	20,201	No	4	M	Direct
Common Stock	Disposition	2023-01-27	441	$7.49	19,760	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-01-27	1,233	$0.00	1,233	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,700			No	4	M	Direct

Footnotes

Restricted stock units convert into common stock on a one-for-one basis.
Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
On January 27, 2022 (the "Grant Date"), the reporting person was granted 4,933 restricted stock units, vesting in four equal installments on the anniversary of the grant date.